NCT04234659Completed
PPCM Observational Study (Peripartum Cardiomyopathy)
Observational Study for Outcomes for Participants With Cardiogenic Shock and Peripartum Cardiomyopathy
Source: ClinicalTrials.gov · Last updated 23 Feb 2026
Brief summary (registry, in English)
The purpose of this study is to examine the clinical treatment of patients diagnosed with peripartum cardiomyopathy complicated by cardiogenic shock.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 150 (actual)
- First submitted
- 5 Dec 2019
- Start date
- 11 Jan 2021
- Primary completion date
- 5 Aug 2025
- Lead sponsor
- Medical College of Wisconsin
- NCT number
- NCT04234659
What you commit to
- Study type: Observational
- Participants enrolled: 150
- From 11 Jan 2021 to the primary completion date, 5 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- lack of medical records supporting pregnancy, peripartum cardiomyopathy or cardiogenic shock by study definition
- inability of participant to provide informed consent
Who the study is looking for
- Females:
- age ≥ 18 years old at the time of entry into the study
- who have capacity to provide consent for study participation
- with self-reported PPCM complicated by cardiogenic shock
- individuals should have US citizenship
- index event occurring within the continental United States.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical College of Wisconsin Coordinator of this site? Confirm its status | Milwaukee | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.